 | • レポートコード：QFJ1-5877 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、顧みられない熱帯病治療薬＆ワクチンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（マラリア、エボラ、デング熱、シャーガス病、リーシュマニア症、その他）、用途別市場規模（薬、ワクチン）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・顧みられない熱帯病治療薬＆ワクチンの市場動向 ・企業の競争状況、市場シェア ・顧みられない熱帯病治療薬＆ワクチンの種類別市場規模と予測2016-2027（マラリア、エボラ、デング熱、シャーガス病、リーシュマニア症、その他） ・顧みられない熱帯病治療薬＆ワクチンの用途別市場規模と予測2016-2027（薬、ワクチン） ・顧みられない熱帯病治療薬＆ワクチンの北米市場規模2016-2027（アメリカ、カナダ） ・顧みられない熱帯病治療薬＆ワクチンの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・顧みられない熱帯病治療薬＆ワクチンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・顧みられない熱帯病治療薬＆ワクチンの中南米市場規模2016-2027（メキシコ、ブラジル） ・顧みられない熱帯病治療薬＆ワクチンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Artecef BV、GlaxoSmithKline、AstraZeneca、Novartis、Sanofi-Aventis、Ranbaxy Labs、Lupin、Macleods Pharmaceuticals、Cipla、Romark Laboratories、Toyama Chemica） ・結論 |
Neglected tropical diseases (NTDs) are a diverse group of tropical infections which are common in low-income populations in developing regions of Africa, Asia, and the Americas. They are caused by a variety of pathogens such as viruses, bacteria, protozoa and helminths.
Market Analysis and Insights: Global Neglected Tropical Diseases Drugs and Vaccine Market
The global Neglected Tropical Diseases Drugs and Vaccine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neglected Tropical Diseases Drugs and Vaccine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neglected Tropical Diseases Drugs and Vaccine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neglected Tropical Diseases Drugs and Vaccine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neglected Tropical Diseases Drugs and Vaccine market.
Global Neglected Tropical Diseases Drugs and Vaccine Scope and Market Size
Neglected Tropical Diseases Drugs and Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neglected Tropical Diseases Drugs and Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Malaria
Ebola
Dengue
Chagas
Leishmaniasis
Other
Segment by Application
Drugs
Vaccines
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Artecef BV
GlaxoSmithKline
AstraZeneca
Novartis
Sanofi-Aventis
Ranbaxy Labs
Lupin
Macleods Pharmaceuticals
Cipla
Romark Laboratories
Toyama Chemica
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Malaria
1.2.3 Ebola
1.2.4 Dengue
1.2.5 Chagas
1.2.6 Leishmaniasis
1.2.7 Other
1.3 Market by Application
1.3.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Drugs
1.3.3 Vaccines
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Perspective (2016-2027)
2.2 Neglected Tropical Diseases Drugs and Vaccine Growth Trends by Regions
2.2.1 Neglected Tropical Diseases Drugs and Vaccine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Neglected Tropical Diseases Drugs and Vaccine Historic Market Share by Regions (2016-2021)
2.2.3 Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Regions (2022-2027)
2.3 Neglected Tropical Diseases Drugs and Vaccine Industry Dynamic
2.3.1 Neglected Tropical Diseases Drugs and Vaccine Market Trends
2.3.2 Neglected Tropical Diseases Drugs and Vaccine Market Drivers
2.3.3 Neglected Tropical Diseases Drugs and Vaccine Market Challenges
2.3.4 Neglected Tropical Diseases Drugs and Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Revenue
3.1.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Revenue (2016-2021)
3.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Players (2016-2021)
3.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Neglected Tropical Diseases Drugs and Vaccine Revenue
3.4 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio
3.4.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2020
3.5 Neglected Tropical Diseases Drugs and Vaccine Key Players Head office and Area Served
3.6 Key Players Neglected Tropical Diseases Drugs and Vaccine Product Solution and Service
3.7 Date of Enter into Neglected Tropical Diseases Drugs and Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neglected Tropical Diseases Drugs and Vaccine Breakdown Data by Type
4.1 Global Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Type (2016-2021)
4.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Type (2022-2027)
5 Neglected Tropical Diseases Drugs and Vaccine Breakdown Data by Application
5.1 Global Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Application (2016-2021)
5.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size (2016-2027)
6.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
6.2.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2021)
6.2.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2022-2027)
6.2.3 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2027)
6.3 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
6.3.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2021)
6.3.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2022-2027)
6.3.3 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2027)
6.4 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
6.4.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2016-2021)
6.4.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size (2016-2027)
7.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
7.2.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2021)
7.2.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2022-2027)
7.2.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2027)
7.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
7.3.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2021)
7.3.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2022-2027)
7.3.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2027)
7.4 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
7.4.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2016-2021)
7.4.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size (2016-2027)
8.2 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
8.2.1 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2027)
8.3 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
8.3.1 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2027)
8.4 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region
8.4.1 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size (2016-2027)
9.2 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
9.2.1 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2021)
9.2.2 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2022-2027)
9.2.3 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2027)
9.3 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
9.3.1 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2021)
9.3.2 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2022-2027)
9.3.3 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2027)
9.4 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
9.4.1 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2016-2021)
9.4.2 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size (2016-2027)
10.2 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
10.2.1 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2027)
10.3 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
10.3.1 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2027)
10.4 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
10.4.1 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Artecef BV
11.1.1 Artecef BV Company Details
11.1.2 Artecef BV Business Overview
11.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Introduction
11.1.4 Artecef BV Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
11.1.5 Artecef BV Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Introduction
11.2.4 GlaxoSmithKline Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
11.2.5 GlaxoSmithKline Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Introduction
11.3.4 AstraZeneca Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
11.3.5 AstraZeneca Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Introduction
11.4.4 Novartis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Sanofi-Aventis
11.5.1 Sanofi-Aventis Company Details
11.5.2 Sanofi-Aventis Business Overview
11.5.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Introduction
11.5.4 Sanofi-Aventis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
11.5.5 Sanofi-Aventis Recent Development
11.6 Ranbaxy Labs
11.6.1 Ranbaxy Labs Company Details
11.6.2 Ranbaxy Labs Business Overview
11.6.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Introduction
11.6.4 Ranbaxy Labs Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
11.6.5 Ranbaxy Labs Recent Development
11.7 Lupin
11.7.1 Lupin Company Details
11.7.2 Lupin Business Overview
11.7.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Introduction
11.7.4 Lupin Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
11.7.5 Lupin Recent Development
11.8 Macleods Pharmaceuticals
11.8.1 Macleods Pharmaceuticals Company Details
11.8.2 Macleods Pharmaceuticals Business Overview
11.8.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Introduction
11.8.4 Macleods Pharmaceuticals Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
11.8.5 Macleods Pharmaceuticals Recent Development
11.9 Cipla
11.9.1 Cipla Company Details
11.9.2 Cipla Business Overview
11.9.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Introduction
11.9.4 Cipla Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
11.9.5 Cipla Recent Development
11.10 Romark Laboratories
11.10.1 Romark Laboratories Company Details
11.10.2 Romark Laboratories Business Overview
11.10.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Introduction
11.10.4 Romark Laboratories Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
11.10.5 Romark Laboratories Recent Development
11.11 Toyama Chemica
11.11.1 Toyama Chemica Company Details
11.11.2 Toyama Chemica Business Overview
11.11.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Introduction
11.11.4 Toyama Chemica Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
11.11.5 Toyama Chemica Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Malaria
Table 3. Key Players of Ebola
Table 4. Key Players of Dengue
Table 5. Key Players of Chagas
Table 6. Key Players of Leishmaniasis
Table 7. Key Players of Other
Table 8. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Regions (2016-2021)
Table 12. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Regions (2022-2027)
Table 14. Neglected Tropical Diseases Drugs and Vaccine Market Trends
Table 15. Neglected Tropical Diseases Drugs and Vaccine Market Drivers
Table 16. Neglected Tropical Diseases Drugs and Vaccine Market Challenges
Table 17. Neglected Tropical Diseases Drugs and Vaccine Market Restraints
Table 18. Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Players (2016-2021)
Table 20. Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neglected Tropical Diseases Drugs and Vaccine as of 2020)
Table 21. Ranking of Global Top Neglected Tropical Diseases Drugs and Vaccine Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Neglected Tropical Diseases Drugs and Vaccine Product Solution and Service
Table 25. Date of Enter into Neglected Tropical Diseases Drugs and Vaccine Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Type (2016-2021)
Table 29. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Application (2016-2021)
Table 33. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2022-2027) & (US$ Million)
Table 65. Artecef BV Company Details
Table 66. Artecef BV Business Overview
Table 67. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product
Table 68. Artecef BV Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021) & (US$ Million)
Table 69. Artecef BV Recent Development
Table 70. GlaxoSmithKline Company Details
Table 71. GlaxoSmithKline Business Overview
Table 72. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product
Table 73. GlaxoSmithKline Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021) & (US$ Million)
Table 74. GlaxoSmithKline Recent Development
Table 75. AstraZeneca Company Details
Table 76. AstraZeneca Business Overview
Table 77. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product
Table 78. AstraZeneca Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021) & (US$ Million)
Table 79. AstraZeneca Recent Development
Table 80. Novartis Company Details
Table 81. Novartis Business Overview
Table 82. Novartis Neglected Tropical Diseases Drugs and Vaccine Product
Table 83. Novartis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021) & (US$ Million)
Table 84. Novartis Recent Development
Table 85. Sanofi-Aventis Company Details
Table 86. Sanofi-Aventis Business Overview
Table 87. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product
Table 88. Sanofi-Aventis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021) & (US$ Million)
Table 89. Sanofi-Aventis Recent Development
Table 90. Ranbaxy Labs Company Details
Table 91. Ranbaxy Labs Business Overview
Table 92. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product
Table 93. Ranbaxy Labs Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021) & (US$ Million)
Table 94. Ranbaxy Labs Recent Development
Table 95. Lupin Company Details
Table 96. Lupin Business Overview
Table 97. Lupin Neglected Tropical Diseases Drugs and Vaccine Product
Table 98. Lupin Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021) & (US$ Million)
Table 99. Lupin Recent Development
Table 100. Macleods Pharmaceuticals Company Details
Table 101. Macleods Pharmaceuticals Business Overview
Table 102. Macleods Pharmaceuticals Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021) & (US$ Million)
Table 103. Macleods Pharmaceuticals Recent Development
Table 104. Cipla Company Details
Table 105. Cipla Business Overview
Table 106. Cipla Neglected Tropical Diseases Drugs and Vaccine Product
Table 107. Cipla Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021) & (US$ Million)
Table 108. Cipla Recent Development
Table 109. Romark Laboratories Company Details
Table 110. Romark Laboratories Business Overview
Table 111. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product
Table 112. Romark Laboratories Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021) & (US$ Million)
Table 113. Romark Laboratories Recent Development
Table 114. Toyama Chemica Company Details
Table 115. Toyama Chemica Business Overview
Table 116. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product
Table 117. Toyama Chemica Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021) & (US$ Million)
Table 118. Toyama Chemica Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Type: 2020 VS 2027
Figure 2. Malaria Features
Figure 3. Ebola Features
Figure 4. Dengue Features
Figure 5. Chagas Features
Figure 6. Leishmaniasis Features
Figure 7. Other Features
Figure 8. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application: 2020 VS 2027
Figure 9. Drugs Case Studies
Figure 10. Vaccines Case Studies
Figure 11. Neglected Tropical Diseases Drugs and Vaccine Report Years Considered
Figure 12. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Regions: 2020 VS 2027
Figure 15. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Regions (2022-2027)
Figure 16. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Players in 2020
Figure 17. Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neglected Tropical Diseases Drugs and Vaccine as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2020
Figure 19. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Type (2016-2021)
Figure 20. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Type (2022-2027)
Figure 21. North America Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2016-2027)
Figure 23. North America Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2016-2027)
Figure 24. North America Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2016-2027)
Figure 25. United States Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2016-2027)
Figure 29. Europe Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2016-2027)
Figure 30. Europe Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2016-2027)
Figure 31. Germany Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Share by Region (2016-2027)
Figure 41. China Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2016-2027)
Figure 49. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2016-2027)
Figure 50. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2016-2027)
Figure 51. Mexico Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2016-2027)
Figure 57. Turkey Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Artecef BV Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
Figure 62. AstraZeneca Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
Figure 64. Sanofi-Aventis Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
Figure 65. Ranbaxy Labs Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
Figure 66. Lupin Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
Figure 67. Macleods Pharmaceuticals Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
Figure 68. Cipla Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
Figure 69. Romark Laboratories Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
Figure 70. Toyama Chemica Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の顧みられない熱帯病（NTD）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Neglected Tropical Disease (NTD) Treatment Market The global Neglected Tropical Disease (NTD) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in an…- 顧みられない熱帯病（NTD）診断のグローバル市場調査 2019年 The global Neglected Tropical Diseases Diagnosis market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Neglected Tropical Diseases Diagnosis volume and value at global level, regional level and company le…
- 世界の顧みられない熱帯病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Neglected Tropical Disease Treatments Market The global Neglected Tropical Disease Treatments market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and…
- 世界の中枢神経系疾患治療薬市場規模・現状・予測（2021年-2027年） A drug used to treat neurological diseases that affect the functioning of the brain or spinal cord in the central nervous system Market Analysis and Insights: Global Drugs for Central Nervous System Diseases Market The global Drugs for Central Nervous System Diseases market size is projected to reac…
- 中枢神経系疾患薬品のグローバル市場：規模・現状・予測2019-2025 A drug used to treat neurological diseases that affect the functioning of the brain or spinal cord in the central nervous systemIn 2018, the global Drugs for Central Nervous System Diseases market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of x…